I. Expression across cell types
Name | Number of supported studies  | Average coverage | |
|---|---|---|---|
| endothelial cell | 27 studies | 39% ± 18% | |
| pericyte | 23 studies | 34% ± 17% | |
| smooth muscle cell | 17 studies | 32% ± 13% | |
| oligodendrocyte | 16 studies | 44% ± 19% | |
| glutamatergic neuron | 13 studies | 56% ± 26% | |
| oligodendrocyte precursor cell | 13 studies | 45% ± 18% | |
| microglial cell | 13 studies | 39% ± 13% | |
| astrocyte | 12 studies | 41% ± 16% | |
| GABAergic neuron | 10 studies | 51% ± 26% | |
| macrophage | 10 studies | 37% ± 18% | |
| fibroblast | 10 studies | 25% ± 7% | |
| endothelial cell of lymphatic vessel | 9 studies | 31% ± 17% | |
| adipocyte | 9 studies | 32% ± 9% | |
| B cell | 7 studies | 24% ± 9% | |
| neuron | 7 studies | 43% ± 15% | |
| epithelial cell | 7 studies | 29% ± 15% | |
| interneuron | 7 studies | 54% ± 25% | |
| plasmacytoid dendritic cell | 7 studies | 27% ± 6% | |
| T cell | 7 studies | 20% ± 4% | |
| naive B cell | 6 studies | 20% ± 2% | |
| retina horizontal cell | 6 studies | 28% ± 14% | |
| myeloid cell | 6 studies | 20% ± 4% | |
| retinal ganglion cell | 5 studies | 32% ± 19% | |
| capillary endothelial cell | 5 studies | 20% ± 4% | |
| amacrine cell | 5 studies | 31% ± 9% | |
| endothelial cell of vascular tree | 5 studies | 32% ± 20% | |
| monocyte | 5 studies | 27% ± 12% | |
| natural killer cell | 5 studies | 33% ± 25% | |
| dendritic cell | 5 studies | 22% ± 5% | |
| granule cell | 4 studies | 47% ± 10% | |
| mucosal invariant T cell | 4 studies | 20% ± 3% | |
| CD16-negative, CD56-bright natural killer cell, human | 4 studies | 16% ± 1% | |
| CD4-positive, alpha-beta T cell | 4 studies | 22% ± 3% | |
| ciliated cell | 4 studies | 22% ± 6% | |
| Mueller cell | 4 studies | 27% ± 9% | |
| CD8-positive, alpha-beta memory T cell | 4 studies | 30% ± 20% | |
| club cell | 4 studies | 24% ± 9% | |
| type I pneumocyte | 4 studies | 28% ± 8% | |
| type II pneumocyte | 4 studies | 22% ± 7% | |
| basal cell | 4 studies | 30% ± 17% | |
| goblet cell | 4 studies | 36% ± 26% | |
| mesothelial cell | 4 studies | 36% ± 16% | |
| differentiation-committed oligodendrocyte precursor | 3 studies | 47% ± 13% | |
| GABAergic interneuron | 3 studies | 53% ± 3% | |
| glial cell | 3 studies | 26% ± 9% | |
| progenitor cell | 3 studies | 32% ± 9% | |
| CD16-positive, CD56-dim natural killer cell, human | 3 studies | 17% ± 2% | |
| precursor B cell | 3 studies | 22% ± 3% | |
| pro-B cell | 3 studies | 22% ± 1% | |
| cardiac muscle cell | 3 studies | 20% ± 1% | |
| vein endothelial cell | 3 studies | 38% ± 18% | |
| GABAergic amacrine cell | 3 studies | 32% ± 14% | |
| glycinergic amacrine cell | 3 studies | 26% ± 5% | |
| retinal rod cell | 3 studies | 25% ± 7% | |
| CD8-positive, alpha-beta T cell | 3 studies | 32% ± 13% | |
| mast cell | 3 studies | 35% ± 21% | |
| myofibroblast cell | 3 studies | 28% ± 7% | |
| hepatocyte | 3 studies | 42% ± 19% | |
| abnormal cell | 3 studies | 24% ± 10% | |
| connective tissue cell | 3 studies | 20% ± 4% | |
| ependymal cell | 3 studies | 37% ± 17% | |
| alveolar macrophage | 3 studies | 28% ± 10% | |
| group 3 innate lymphoid cell | 3 studies | 33% ± 3% | |
| lymphocyte | 3 studies | 32% ± 18% | |
| leukocyte | 3 studies | 36% ± 13% | |
| mural cell | 3 studies | 41% ± 8% | |
| mucus secreting cell | 3 studies | 25% ± 4% | |
| enteroendocrine cell | 3 studies | 18% ± 2% |
